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specifically. In contrast, we have shown that infection of a variety of mammalian cells with flaviviruses is accompanied by an increase in the expression of MHC-I and MHC-II, intracellular adhesion molecule-1 (CD54), vascular adhesion cellular molecule-1 (CD106), and Eselectin within 24-48 h on a wide variety of diploid cells from mice, rats, and humans.
West Nile virus (WNV)-induced increase in MHC-I expression in particular is augmented by the action of endogenously secreted interferons (IFNs) [5] [6] [7] [8] [9] [10] . However, we have halted the MHC-I-enhancing effects of WNV-induced, endogenously secreted IFN by adding neutralizing anti-IFN-a/b antibody to WNV-infected cells [5] . Furthermore, we have shown that WNV infection induces MHC-I expression in IFN-refractory preimplantation blastocysts, which lack surface expression of MHC-I [11] . These findings indicate that upregulation of MHC-I by flavivirus is at least partially independent of the actions of endogenous type 1 IFN secretion. In the present study, we extend the observations that WNV infection is associated with IFNindependent up-regulation of MHC-I by demonstrating this effect in cells from type 1 IFN receptor gene mouse embryo fibroblasts (MEFs) by WNV was associated with activation of NF-kB, whereas in wt MEFs, the up-regulation of MHC-I by IFN was independent of NF-kB activation. ]) [12] between the ages of 6 and 16 weeks were used. The guidelines of the National Health and Medical Research Council of Australia were strictly adhered to in all procedures involving animals.
MATERIALS AND METHODS

Culture of
MEFs were isolated from normal mouse fetuses at 14 days' gestation. In brief, 6-9 embryos were aseptically transferred from the uterus to a 100-mm-diameter petri dish containing 10 mL of PBS (Gibco). The heads and all visible organs were removed, and each embryo was finely minced with scissors. The tissue fragments were trypsinized with 40 mL of 0.25% trypsin (Gibco) and incubated in a flask with stirring for 30 min at room temperature. The trypsin digest was passed through 120-mm gauze, and the filtered cells were pelleted by centrifugation, resuspended in Dulbecco's modified Eagle medium (DMEM; Gibco) with 10% fetal bovine serum (FBS; Gibco), and seeded at 10 6 cells/ 175-cm 2 flask (Falcon) in a humidified atmosphere of 5% CO 2 in air at 37ЊC (standard culture conditions; SCCs), until confluence. Primary MEFs were trypsinized and stored at 10 6 cells/ 1-mL cryotube in liquid nitrogen and used as stock for the experiments.
Preparation and treatment of virus stocks. Vero cells were grown to confluence in DMEM/FBS under SCCs in 80-cm 2 tissue culture flasks. At confluence, the medium was removed, and the cells were infected with 10 8 pfu of WNV stock in 1 mL of DMEM/FBS (MOI of 5) or mock-infected with 1 mL of DMEM for 1 h at 37ЊC, and then 20 mL of DMEM/FBS was added. After 48 h of incubation at 37ЊC, supernatant was transferred to a 50-mL tube (Falcon) and centrifuged at 1500 g for 15 min at 4ЊC, and the supernatant was stored in aliquots at Ϫ80ЊC.
Infection of cells. wt or IFNAR Ϫ/Ϫ MEFs were seeded at cells/well (confluent) or cells/well (noncon- 6 6 0.5 ϫ 10 0.1 ϫ 10 fluent) in 6-well plates (Falcon) with 2 mL of DMEM/FBS and were incubated under SCCs overnight. The medium was removed, and the monolayers were infected with a virus inoculum of 5 pfu/cell diluted in 0.5 mL of DMEM and then were incubated for 1 h under SCCs. After removal of the virus inoculum, cells were washed twice with 1 mL of PBS and incubated with 2 mL of DMEM/FBS under SCCs for 24 or 48 h. Mock-infected MEFs were treated as described above, but no virus was present in the inoculum. Calculations of virus output were corrected for the number of cells in the original culture.
Cell 6 6 0.1 ϫ 10 0.5 ϫ 10 night under SCCs. Then the MEFs were infected with WNV or mock-infected and incubated under SCCs for 24 h. The coverslips with infected MEFs were washed twice with PBS, and the MEFs were fixed with acetone at Ϫ20ЊC for 20 min. After 2 washes with PBS, primary mouse anti-WNV antibody was added, and the cells were incubated on ice for 60 min. Cells were washed twice with PBS, FITC-SAM was added, and the cells were incubated for 60 min more. Then the cells were washed 3 times with PBS, and Hoechst 33342 (bisbenzimide; 5 mg/mL; Sigma) was added to visualize MEF nuclei. The coverslips were mounted on microscope slides with a small drop of glycerol. The percentage of infected cells was determined by dividing the number of MEFs labeled with FITC (green) by the total number of MEF nuclei (blue) and multiplying this ratio by 100. At least 100 cells were counted in each field, and 5 fields were counted so that the mean and SD could be calculated.
Electrophoretic mobility shift assays (EMSAs) for NF-kB activation. wt or IFNAR Ϫ/Ϫ MEFs were harvested by trypsinization and centrifugation, trypsin was inactivated with DMEM/FBS, and DMEM/FBS was washed off with PBS. The cell pellet was resuspended in 4 volumes of total cell protein extraction buffer A (20 mmol/L HEPES [pH 7.9], 300 mmol/ L NaCl, 0.5% NP-40, 0.1 mmol/L EDTA, 10% glycerol, 1 mmol/ L dithiothreitol (DTT), 0.4 mmol/L phenylmethylsulfonylfluoride (PMSF), 3 mg/mL aprotinin, and 1 mg/mL leupeptin). The cell lysate was incubated on ice for 30 min and then centrifuged for 5 min at 13,000 g at 4ЊC. Protein content was determined by the Bradford dye-binding assay (Bio-Rad), and protein extract aliquots were stored at Ϫ80ЊC and used within 1 month. Equal amounts of cell protein (10 mg) from each sample were incubated for 30 min at 4ЊC with buffer B (10 mmol/L HEPES [pH 7.9], 12 mmol/L KCl, 1.5 mmol/L MgCl 2 , 0.5 mmol/L EDTA, 2 mmol/L DTT, and 0.1% PMSF), 20 mg of bovine serum albumin, 2 mg of poly(dI-dC), and 1 ng of oligonucleotide probe. Double-stranded oligonucleotide of NF-kB (Promega) was endlabeled with g-32 P-ATP by using T4 polynucleotide kinase (Promega). The complex of 32 P-labeled oligonucleotide and NF-kB was resolved from excess labeled oligonucleotide by electrophoresis in 5% polyacrylamide gels. The gel was dried and autoradiographed. For the supershift assays, analysis was done with specific antibodies to the p50, p65 (RelA), and c-Rel subunits of NF-kB (Santa Cruz Biotechnology) by adding them to binding reaction for 2 h at 4ЊC before adding the 32 P-labeled oligonucleotide.
Transactivation assays. The RAWa4 LTR-luc cell line [13] , which derives from the RAW264.7 cell line, has been stably transfected with a construct consisting of the HIV long terminal repeat regulatory elements, containing 2 NF-kB-binding sites, as well as other transcription factor-binding sites [14, 15] . These sites drive expression of the luciferase reporter gene. A luciferase assay system kit (Promega) was used to quantify luciferase activity in RAWa4 LTR-luc cells. RAWa4 LTR-luc cells were seeded at 10 6 cells/well in DMEM/FBS in 6-well trays and cultured overnight under SCCs. The cells were infected with WNV at 5 pfu/cell for 2 h, treated with 200 U/mL IFN-b for varying times, or left uninfected. The cells were washed twice with PBS, and the PBS was removed before lysis in 200 mL of reporter lysis buffer for 15 min at room temperature. The cell lysates were collected and clarified by centrifugation at 13,000 g for 5 min at 4ЊC. The lysates were aspirated from any pellets and stored at Ϫ80ЊC. The cell lysate samples were thawed and equilibrated to room temperature, and the protein concentrations of the cell lysates were determined using a Bradford dyebinding assay, to normalize luciferase activity data. Twenty microliters of each sample was mixed with 100 mL of luciferase assay reagent in a glass tube. The glass tube was wiped with 100% ethanol to prevent static electricity and placed immediately in a luminometer (Packard). Light emissions were counted for six 10-s intervals. The protein concentration was normalized by dividing the protein concentration of the experimental sample by the protein concentration of the untreated control sample. Luciferase activity was calculated by correcting the light emissions for the experimental sample for the normalized protein concentration. The mean luciferase activity and SD were determined, and the results were expressed in arbitrary units.
Statistical analysis. The statistical difference between the means was determined by Student's t test.
was consid-P ! .05 ered to be statistically significant. The results of our previous studies [5, 11] strongly suggest that WNV up-regulates MHC-I in an IFN-independent manner. However, these data do not absolutely exclude the possibility that endogenous type 1 IFN plays a role in this effect. When neutralizing anti-IFN-a/b antibody is added to cultures of WNV-infected cells, the possibility exists that IFN could still bind the type 1 IFN receptor and stimulate the signals required to up-regulate MHC-I before being neutralized by antibody [5] . Furthermore, WNV-induced MHC-I up-regulation on IFN-refractory preimplantation blastocysts may be unique to these highly specialized cells and may not reflect activity in other diploid cell types [11] . To absolutely exclude the possibility that the effects of WNV-induced endogenous type 1 IFN production cause the up-regulation of MHC-I seen with WNV infection, we infected or mock-infected both wt MEFs and MEFs derived from IFNAR Ϫ/Ϫ mice and determined the level of MHC-I expression by flow cytometry (figure 1). Our results show that WNV induced up-regulation of MHC-I on both cell types. The up-regulation of MHC-I on IFNAR Ϫ/Ϫ MEFs was always several-fold less than that on wt MEFs, which is consistent with the observation that endogenous secreted IFN enhances the up-regulation of MHC-I by WNV. 
RESULTS
Infection of IFNAR
MEFs (figure 2). The increase in MHC-I was greater in wt
MEFs treated with the supernatant from WNV-infected wtMEFs than in those treated with the supernatant from WNVinfected IFNAR Ϫ/Ϫ MEFs, which indicates that wt MEFs produce more functional type 1 IFN than do IFNAR Ϫ/Ϫ MEFs, even though levels of infection are higher in the IFNAR Ϫ/Ϫ MEFs.
Importantly, the results from the IFNAR Ϫ/Ϫ MEFs used as controls in these supernatant experiments also indicate that no other cytokine produced by MEFs in response to WNV contributes significantly to the up-regulation of MHC-I in MEFs. Association of up-regulation of MHC-I by WNV with activation of NF-kB and independence from type 1 IFNs. WNV-induced up-regulation of cell-surface MHC-I has been shown to be associated with NF-kB activation [16] . We wished to investigate whether the IFN-independent up-regulation of MHC-I was also associated with NF-kB activation. wt and IFNAR Ϫ/Ϫ MEFs were infected with WNV or mock-infected, and total cell proteins were extracted. Equal amounts of protein were analyzed in an EMSA using 32 P-labeled oligonucleotide with a high-affinity binding site for NF-kB. WNV infec- 6, and 8) . Anti-c-Rel had no effect (lane 5). Goat serum was added as a control and did not alter the mobility of the complex (lane 9). These data identify p65 and p50 as the components that bind the WNV-induced NF-kB complex.
We have shown that WNV infection can up-regulate MHC-I expression independently of endogenous type 1 IFN secretion. Furthermore, WNV-induced MHC-I expression is associated with NF-kB activation. To further separate the MHC-I-inducing activity of IFN-b from that of WNV, wt MEFs were treated with 200 U/mL IFN-b for variable times that had previously been adjusted for maximal effect (data not shown) and then were infected with WNV for 24 h or left untreated. After incubation under SCCs, the cells were washed, proteins were extracted, and equal amounts of protein were analyzed in an EMSA using a 32 P-labeled oligonucleotide with a high-affinity binding site for NF-kB. As shown previously, WNV infection for 24 h induced novel DNA binding activity. No activation of NF-kB in IFN-b-treated wt MEFs could be detected at 3 h ( figure 5, lanes 4-6), 8 h (lanes 7-9) , or 24 h (lanes [10] [11] [12] , as opposed to untreated controls (lanes 1-3) . WNV-induced NFkB activation was used as a positive control (lane 13). These data indicate that MHC-I can be up-regulated in an NF-kBindependent manner by IFN-b. However, WNV-induced MHC-I up-regulation clearly involved activation of the NF-kB transcription factor. Furthermore, the addition of 200 U/mL exogenous IFN-b to WNV-infected wt MEFs leads to an even greater up-regulation of MHC-I than does the addition of either IFN-b or WNV alone ( figure 6 ). This supports the conclusion that the maximal up-regulation of MHC-I requires NF-kB activation and some other NF-kB-independent pathway, usually mediated by IFN-b.
To confirm the absence of activation of NF-kB by type 1 IFN, we used a reporter gene assay. Abrogation of WNV-induced activation of NF-kB and of up-regulation of MHC-I by the serine protease inhibitor Nbenzoyl-l-tosyl-l-phenylalanine (BTEE). Activation of NFkB, which is sequestered in the cytoplasm, occurs after release from the prototypic 37-kDa cytoplasmic inhibitor (I)-kB. Release of NF-kB from I-kB in the cytosol is mediated by its phosphorylation and subsequent degradation, which can be induced through a variety of pathways [18] . We hypothesized that the protease inhibitor BTEE, which inhibits serine phosphorylation and prevents I-kB degradation, could inhibit activation of NF-kB and subsequent up-regulation of MHC-I expression. We tested the role of serine phosphorylation in WNV-induced NF-kB activation by treating cells with the antagonist BTEE for 24 h. BTEE decreased the activation of NFkB at concentrations of 50 and 100 mg/mL (figure 8). Similarly, up-regulation of MHC-I was decreased when the cells were infected with WNV in the presence of 50 mg/mL BTEE, and WNV-induced MHC-I up-regulation was totally abrogated in the presence of 100 mg/mL BTEE (figure 9). to their receptor has a positive effect on their production. This also supports the hypothesis that the induction of IFN-a/b by virus occurs via a biphasic mechanism. Initially, IFN-b is induced by a pathway in which interferon response factor-3 plays an important role as transcription activator [19] . Subsequently, the early secreted IFN-b feeds back to induce more IFN-a and IFNb through the type I IFN receptor. IFN-a cannot be produced by embryonic fibroblasts derived from mice lacking the IFN-b gene, which suggests that IFN-a production is dependent on IFN-b via binding to the type I IFN receptor [20] . Unlike IFNb, the IFN-a promoter does not contain an NF-kB-binding site.
DISCUSSION
This could be another reason that IFN-a is not induced during the first stage of infection, because NF-kB is believed to be the central and initial factor in up-regulation of IFN-b gene expression. Our experiments indicate that IFN-b does not induce NF-kB activation. Therefore, it follows from our experiments that the initiation of transcription of the IFN-b gene might result from WNV-induced NF-kB activation. Although WNV infection causes activation of NF-kB and NF-kB activation can lead to increased transcription of type 1 IFN genes [18] , it is probable that at least some of the MHC-I up-regulation mediated by WNV-induced NF-kB activation results from endogenous type 1 IFN-induced secretion. However, maximal up-regulation of MHC-I occurs not with WNV or IFN alone, but when WNV infection and treatment with exogenous IFN are combined. This confirms that maximal MHC-I up-regulation requires both an NF-kB-dependent and an NF-kB-independent signal (figure 10). Thus, the lower level of MHC-I up-regulation in IFNAR
MEFs, compared with wt MEFs, is not the result of any failure of WNV infection of these cells but rather of the inability of WNV-induced endogenously secreted IFN to bind the IFN receptor and induce up-regulation of cell-surface MHC-I in these cells. These data are consistent with the proposition that WNV infection can up-regulate MHC-I expression in a manner independent of endogenous IFN production. The WNV-specific up-regulation of MHC-I depends on the activation of NF-kB, whereas the up-regulation of MHC-I by endogenous WNVinduced type 1 IFN binding of the IFN receptor is independent of NF-kB activation.
